Anti-CCP-positive without synovitis: MRI tenosynovitis and ultrasound erosions predicted progression

Design

Prospective cohort study

Population

130 anti-CCP-positive individuals with musculoskeletal symptoms and no clinical synovitis

Primary outcome

Progression to inflammatory arthritis

Effect

36.9% progressed over a median 36.5 months; MRI tenosynovitis plus ultrasound erosions HR 5.83

This prospective cohort followed 130 people who were anti-CCP positive, had musculoskeletal symptoms and no clinical synovitis. All had contrast-enhanced 3 T MRI of the most symptomatic hand and both feet, and an ultrasound protocol covering 36 joints and 18 tendons.

Everyone had at least one RAMRIS abnormality on MRI, including those with normal ultrasound, whereas ultrasound abnormalities were seen in 25.4%. Over a median 36.5 months, 48 (36.9%) progressed to inflammatory arthritis. Hand tenosynovitis was the only MRI feature consistently linked to progression, and ultrasound bone erosions were the most consistent ultrasound predictor. Having both gave a hazard ratio of 5.83.

MRI abnormalities are very common at baseline, so a positive scan alone is not specific. The authors note that the cost and feasibility of combined hand MRI and wide ultrasound still need study. Both tests are specialist resources, and the findings come from a single cohort without external validation.

• Anti-CCP positivity with joint pain and no synovitis is an at-risk state; plan close follow-up rather than reassurance.
• Hand tenosynovitis on MRI and ultrasound erosions were the features linked to progression.
• Do not treat a non-specific MRI abnormality as diagnostic; all patients had one.
• Re-examine promptly if new swelling appears, and record joint counts at each visit.
• Reserve imaging for centres able to read it and discuss research or prevention studies where available.

Why it matters

It points to specific imaging features that separate the third who progress from the rest, a prerequisite for targeted prevention.

Don't overread it

This is a single prospective cohort, and it does not show that treating people with these imaging features prevents arthritis.

The statistics, in plain English

A hazard ratio of 5.83 for having both features means progression happened at a much higher rate than in people with neither, but it comes from a small subgroup, so the interval is likely wide. Because every patient had some MRI abnormality, MRI findings by themselves cannot distinguish who will progress.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.